MA37970B2 - Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocs - Google Patents
Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocsInfo
- Publication number
- MA37970B2 MA37970B2 MA37970A MA37970A MA37970B2 MA 37970 B2 MA37970 B2 MA 37970B2 MA 37970 A MA37970 A MA 37970A MA 37970 A MA37970 A MA 37970A MA 37970 B2 MA37970 B2 MA 37970B2
- Authority
- MA
- Morocco
- Prior art keywords
- combination
- adrenaline
- antidepressant
- shock treatment
- treatment
- Prior art date
Links
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 title abstract 4
- 230000001430 anti-depressive effect Effects 0.000 title abstract 2
- 239000000935 antidepressant agent Substances 0.000 title abstract 2
- 229940005513 antidepressants Drugs 0.000 title abstract 2
- 238000002635 electroconvulsive therapy Methods 0.000 title 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010040560 shock Diseases 0.000 abstract 1
- 230000035939 shock Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
La présente invention concerne une nouvelle combinaison d'adrénaline avec un antidépresseur et l'utilisation de ladite combinaison en tant que composition pharmaceutique dans le traitement des chocs. La composition est destinée à être administrée par injection.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306207 | 2012-10-03 | ||
| PCT/EP2013/070598 WO2014053579A1 (fr) | 2012-10-03 | 2013-10-02 | Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MA20150396A1 MA20150396A1 (fr) | 2015-11-30 |
| MA37970B1 MA37970B1 (fr) | 2016-06-30 |
| MA37970B2 true MA37970B2 (fr) | 2017-10-31 |
Family
ID=47073380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA37970A MA37970B2 (fr) | 2012-10-03 | 2013-10-02 | Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocs |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US20150306065A1 (fr) |
| EP (1) | EP2903607B1 (fr) |
| JP (1) | JP6419074B2 (fr) |
| KR (1) | KR102145786B1 (fr) |
| CN (1) | CN104780916B (fr) |
| AU (1) | AU2013326470B2 (fr) |
| BR (1) | BR112015007524B1 (fr) |
| CA (1) | CA2887330C (fr) |
| CY (1) | CY1119514T1 (fr) |
| DK (1) | DK2903607T3 (fr) |
| EA (1) | EA030763B1 (fr) |
| ES (1) | ES2647597T3 (fr) |
| HR (1) | HRP20171442T1 (fr) |
| HU (1) | HUE034638T2 (fr) |
| IL (1) | IL238120B (fr) |
| IN (1) | IN2015DN02849A (fr) |
| LT (1) | LT2903607T (fr) |
| MA (1) | MA37970B2 (fr) |
| MX (1) | MX359198B (fr) |
| NO (1) | NO2903607T3 (fr) |
| NZ (1) | NZ707124A (fr) |
| PH (1) | PH12015500755A1 (fr) |
| PL (1) | PL2903607T3 (fr) |
| PT (1) | PT2903607T (fr) |
| RS (1) | RS56392B1 (fr) |
| SG (1) | SG11201502645VA (fr) |
| SI (1) | SI2903607T1 (fr) |
| SM (1) | SMT201700502T1 (fr) |
| TN (1) | TN2015000126A1 (fr) |
| WO (1) | WO2014053579A1 (fr) |
| ZA (1) | ZA201502441B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4706648A1 (fr) | 2024-09-05 | 2026-03-11 | Bioprojet | Formulations d'adrénaline et d'antidépresseur |
| EP4706649A1 (fr) | 2024-09-05 | 2026-03-11 | Bioprojet | Utilisation de l'adrénaline pour le traitement des chocs |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3705942A (en) * | 1969-09-29 | 1972-12-12 | Ciba Geigy Corp | Treatment of glaucoma employing imipramine or desmethylimipramine |
| TW200744568A (en) * | 2006-02-28 | 2007-12-16 | Verus Pharmaceuticals Inc | Epinephrine dosing regimens |
| US20070293582A1 (en) * | 2006-06-05 | 2007-12-20 | Malcolm Hill | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
| PT2818184T (pt) * | 2007-11-16 | 2019-01-28 | Aclaris Therapeutics Inc | Composições e métodos para o tratamento de púrpura |
| SE533552C2 (sv) * | 2008-12-30 | 2010-10-26 | Igeloesa Transplantation Science Ab | Förfarande och lösning för behandling av en potentiell organdonator |
| US20100190860A1 (en) * | 2009-01-09 | 2010-07-29 | The Brigham And Women's Hospital, Inc. | Methods for selectively enhancing antinociceptive potency of local anesthetics |
| CN101987198B (zh) * | 2009-08-06 | 2014-08-13 | 北京美倍他药物研究有限公司 | 药物组合物 |
-
2013
- 2013-10-02 PL PL13771500T patent/PL2903607T3/pl unknown
- 2013-10-02 IN IN2849DEN2015 patent/IN2015DN02849A/en unknown
- 2013-10-02 JP JP2015535014A patent/JP6419074B2/ja active Active
- 2013-10-02 HU HUE13771500A patent/HUE034638T2/en unknown
- 2013-10-02 MA MA37970A patent/MA37970B2/fr unknown
- 2013-10-02 EA EA201500374A patent/EA030763B1/ru not_active IP Right Cessation
- 2013-10-02 PT PT137715009T patent/PT2903607T/pt unknown
- 2013-10-02 BR BR112015007524-0A patent/BR112015007524B1/pt active IP Right Grant
- 2013-10-02 RS RS20170973A patent/RS56392B1/sr unknown
- 2013-10-02 CN CN201380057617.0A patent/CN104780916B/zh active Active
- 2013-10-02 SG SG11201502645VA patent/SG11201502645VA/en unknown
- 2013-10-02 KR KR1020157010740A patent/KR102145786B1/ko active Active
- 2013-10-02 US US14/433,549 patent/US20150306065A1/en not_active Abandoned
- 2013-10-02 SM SM20170502T patent/SMT201700502T1/it unknown
- 2013-10-02 AU AU2013326470A patent/AU2013326470B2/en active Active
- 2013-10-02 WO PCT/EP2013/070598 patent/WO2014053579A1/fr not_active Ceased
- 2013-10-02 EP EP13771500.9A patent/EP2903607B1/fr active Active
- 2013-10-02 NO NO13771500A patent/NO2903607T3/no unknown
- 2013-10-02 DK DK13771500.9T patent/DK2903607T3/en active
- 2013-10-02 HR HRP20171442TT patent/HRP20171442T1/hr unknown
- 2013-10-02 CA CA2887330A patent/CA2887330C/fr active Active
- 2013-10-02 SI SI201330817T patent/SI2903607T1/sl unknown
- 2013-10-02 MX MX2015004323A patent/MX359198B/es active IP Right Grant
- 2013-10-02 NZ NZ707124A patent/NZ707124A/en unknown
- 2013-10-02 ES ES13771500.9T patent/ES2647597T3/es active Active
- 2013-10-02 LT LTEP13771500.9T patent/LT2903607T/lt unknown
-
2015
- 2015-04-02 TN TNP2015000126A patent/TN2015000126A1/fr unknown
- 2015-04-02 IL IL238120A patent/IL238120B/en active IP Right Grant
- 2015-04-06 PH PH12015500755A patent/PH12015500755A1/en unknown
- 2015-04-10 ZA ZA2015/02441A patent/ZA201502441B/en unknown
-
2017
- 2017-10-31 CY CY20171101135T patent/CY1119514T1/el unknown
-
2018
- 2018-12-18 US US16/223,750 patent/US10952987B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA033811B1 (ru) | Стабильные бесконсервантные мидриатические и противовоспалительные растворы для инъекций | |
| MX370903B (es) | Composiciones de ácido percarboxílico estables y sus usos. | |
| MA38273A1 (fr) | Thérapie de combinaison avec des anticorps anti-her3 | |
| MA40308A1 (fr) | Pyridine-2- amides utiles comme agonistes de cb2 | |
| MA39211A1 (fr) | Composés tricycliques comme agents anti-cancers | |
| MX395719B (es) | Composiciones y métodos para el uso de ésteres de forbol. | |
| MY165124A (en) | Semifluorinated alkane compositions | |
| DOP2013000130A (es) | Compuestos de pirimidinona para uso en el tratamiento de las enfermedades o condiciones mediada por lp - pla2 | |
| UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
| BR112015014034A2 (pt) | inibidores de irak e usos dos mesmos | |
| MA38403A1 (fr) | Nouveaux dérivés de pyrazole modulateurs specifiques de cb2 | |
| MA37990B1 (fr) | Benzamides | |
| MA38460A1 (fr) | Dérivés de la purine en tant qu'agonistes du récepteur cb2 | |
| CL2016000019A1 (es) | Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión. | |
| MA20150396A1 (fr) | Combinaison d'adrénaline et d'antidépresseur pour son utilisation dans le traitement des chocs | |
| FR3019465B1 (fr) | Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen | |
| EA201990550A1 (ru) | Офтальмологический препарат, включающий азоловое соединение | |
| MA45639B1 (fr) | Combinaison d'antagonistes purs du récepteur 5-ht6 avec des inhibiteurs d'acétylcholinestérase | |
| AR088600A1 (es) | Composiciones de yodo-povidona | |
| MA38606A1 (fr) | Composition pharmaceutique et son utilisation, ainsi que schéma d'emploi de cette composition pharmaceutique pour la contraception à la demande | |
| MA38931B1 (fr) | Utilisation de l'odiparcil dans le traitement d'une mucopolysaccharidose | |
| EA201500155A1 (ru) | Фармацевтические композиции, содержащие ипидакрин, и их применение для лечения нарушений потенции и нарушений других форм половой активности | |
| FR3015287B1 (fr) | Combinaison de bezafibrate et de resveratrol pour le traitement et la prevention des maladies impliquant un dysfonctionnement energetique des mitochondries. | |
| TH157696A (th) | ตัวคุมของตัวรับที่ยังไม่ได้ระบุจำแนกประเภทที่เกี่ยวข้องกับเรตินอยด์ชนิดแกมมา (ror-แกมมา) สำหรับใช้ในการรักษาโรคทางภูมิต้านตนเองและโรคที่มีอาการอักเสบ | |
| MA35029B1 (fr) | Traitement de l'infection par le virus de l'hépatite c avec l'alisporivir |